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Abstract Members of the CCN family of matricellular
signaling regulators promote cell adhesion through integrins
and heparan sulfate-containing proteoglycans. A paradox of
the CCN field is that, depending on the set of circumstances
examined,individualCCNmoleculescanhavequitedifferent,
and often opposing, effects. In a recent report, Franzen and
colleagues(MolCancerRes.7:1045–1055,2009)s h o wu s i n g
siRNA knockdown that CCN1 (cyr61) is essential for the
proliferation of prostate cancer cells. Intriguingly, on the
other hand, CCN1 also enhances TRAIL-induced apoptosis.
Thus the utility of anti-CCN1 therapy in cancer needs to be
carefully considered in light of these divergent results. The
significance of this paper is discussed.
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CCN proteins mediate a wide range of biological events,
including proliferation, differentiation and migration (Leask
and Abraham 2006). Intriguingly, CCN proteins act with
often divergent biological consequences; for example,
depending on the context, CCN2 (CTGF, connective tissue
growth factor) can be either pro- and anti-apoptotic (Frazier
et al. 1996; Hishikawa et al. 1999). Adequate explanation
of these issues has been controversial.
One possible interpretation of the varying effects of the
CCN proteins has emerged out of the discovery that the CCN
members are matricellular proteins, acting to promote cell
adhesion through integrins and heparan sulfate containing
proteoglycans (HSPGs) (Lau and Lam 1999). In this model,
CCN proteins act on their own as pro-adhesive molecules,
and, as a result of their ability to activate adhesive signaling
pathways, modify signaling responses of cells to other
extracellular ligands (such as growth factors or matrix
proteins). As a result, cells respond differently in response
to extracellular ligands depending on the constellation of the
CCN proteins that are locally available (Perbal 2001).
CCN1 (cyr61) is a potent pro-angiogenic protein that is
essential for cardiovascular development during embryogen-
esis; moreover, its expression in the adult is associated with
pathologies involving angiogenesisand inflammation, includ-
ing play wound healing, atherosclerosis, and tumorigenesis
(Babic et al. 1998;M oe ta l .2002; Mo and Lau 2006). In a
recent report, Franzen and colleagues (2009) show that, in
prostatecarcinomacells,CCN1 can promote cell proliferation
while also mediating TRAIL-induced cytotoxicity. CCN1
independently enhanced adhesion of prostate carcinoma cells
through α6β1 and α6β4 and HSPGs. Using antisense
oligonucleotides, CCN1 knockdown experiments revealed
that endogenous CCN1 is critical for proliferation of prostate
carcinoma cells. Conversely, whereas CCN1 or a low dose of
TRAIL alone did not appreciably affect cell death in normal
or cancerous prostate cells, low amounts of TRAIL resulted
in cell death when cells were adhered to CCN1- or CCN2-
coated surfaces. TRAIL-treated cells adhered to either
vitronectin or laminin did not undergo apoptosis. Moreover,
prostate carcinoma cells treated with CCN1 antisense
oligonucleotides were resistant to TRAIL-induced apoptosis.
The authors found that integrins αvβ3 and α6β4 and the
HSPG syndecan 4 played critical roles in CCN1/TRAIL
cooperation, whereas αvβ5, α5β1, and α6β1 were not
important for this process. Thus the integrins involved with
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those required for cell adhesion to CCN1.
Collectively, these findings indicate that the ECM
microenvironment, and in particular the presence or
absence of CCN proteins, contribute to prostate carcinoma
cell growth and survival, with the overall effect of the CCN
proteins depending on the presence or absence of different
extracellular ligands.
These considerations emphasize on one hand the
complexity of the action of CCN proteins, and on the other
hand the difficulty of generating appropriate cell based
assays to appropriately recapitulate the range of CCN-
dependent activities that are observed in vivo. Moreover,
these results are important for considering the overall anti-
CCN therapies for disease, in that the overall vivo effect of
CCN proteins at particular junctures of development,
homeostasis and pathologies may differ widely.
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